Phenominer Database Results (10 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
DA/Ztm percentage of study population developing experimental arthritis during a period of time squalene (860 mg/ml) Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. joint integrity trait female 0 days 8 100.0 % in vivo visual assessment 0.0 0 69624 1161
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 100.0 % in vivo visual assessment 0.0 0 69722 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 100.0 % in vivo visual assessment 0.0 0 69724 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time Freund's complete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 16 88.0 % in vivo visual assessment 0.0 0 69706 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 9 100.0 % in vivo visual assessment 0.0 0 69714 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time squalene (860 mg/ml) Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. joint integrity trait male 0 days 6 100.0 % in vivo visual assessment 0.0 0 69625 1161
DA/Ztm percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 17 100.0 % in vivo visual assessment 0.0 0 69716 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 9 100.0 % in vivo visual assessment 0.0 0 69720 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 15 100.0 % in vivo visual assessment 0.0 0 69703 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 12 100.0 % in vivo visual assessment 0.0 0 69709 1162